There are 702 resources available
456P - Correlation between pathological complete response (pCR) and survival outcomes in patients with resectable esophageal (EC) or gastroesophageal junction cancer (GEJC): A large, real-world, single-center cohort analysis
Presenter: Marco Airoldi
Session: Poster Display session
457P - Development of absolute 5-year risk prediction model for gastric cancer and comparisons with current guideline in China: A population-based, prospective study
Presenter: Siyi He
Session: Poster Display session
458P - Treatability with combination chemotherapy and eligibility for addition of new drugs in all gastroesophageal cancer patients referred for medical treatment 2016-2022 at a tertiary centre serving 540.000 inhabitants
Presenter: Kaisa Lehtomaki
Session: Poster Display session
459P - Layer analysis based on RNA-seq data of TCGA reveals gastric cancer's molecular complexity
Presenter: Ismael Ghanem
Session: Poster Display session
460P - Real-world study of ramucirumab and paclitaxel as =2nd-line therapy in patients with HER2-positive gastroesophageal cancer
Presenter: Yvonne Bach
Session: Poster Display session
461P - Finding the minimum number of retrieved lymph nodes and negative lymph nodes in gastric cancer surgery: A large-scale retrospective study from China
Presenter: Jie Chen
Session: Poster Display session
462P - Noninterventional cohort study of biomarker testing and treatment patterns in patients with advanced gastric or gastroesophageal junction (G/GEJ) cancer
Presenter: Samuel Klempner
Session: Poster Display session
463P - A real-world study to evaluate biomarker testing and treatment management in patients with locally advanced unresectable or metastatic G/GEJ adenocarcinoma in France, Germany, Italy, Spain, UK and Canada: Adelphi Real World G/GEJ cancer disease specific p
Presenter: Florian Lordick
Session: Poster Display session
464P - Enhancing management of localized gastric cancer: The added value of prophylactic HIPEC and IORT to conventional surgery
Presenter: Shouki Bazarbashi
Session: Poster Display session
465P - Timing of first-line palliative systemic therapy in metastatic Esophagogastric cancer (mEGC): A European Delphi study
Presenter: Denice Kamp
Session: Poster Display session